NACL Industries LimitedQ1 FY27 Results & Financial Update
NACL Industries Limited: Q1 FY27 consolidated results and company financials – revenue ₹383.33 Cr, PAT ₹20.84 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceCurrent reported figures.Change figures appear when a comparable reported period is available.
Find an answer
Ask this result
Chart · Market context
NACL Industries price & chart
Market priceLoading…
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore NACL Industries Q1 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
During the first quarter of fiscal year 2027 (ended June 30, 2026), NACL Industries recorded consolidated revenue from operations of INR 383.33 crore and total income of INR 385.22 crore. Profit before tax (PBT) for the quarter stood at INR 28.33 crore, after accounting for finance costs, depreciation, and other operational expenses.
Net profit after tax (PAT) for the quarter was reported at INR 20.84 crore, resulting in a basic and diluted earnings per share (EPS) of INR 0.89. Total tax expense for the period amounted to INR 7.49 crore.
The board of directors approved a proposal for the divestment of the company's entire equity stake held in its associate company, Nasense Labs Private Limited, to Mr. Kanumuru Satyanarayana Raju for a total cash consideration of INR 8,15,29,967. Upon completion of this transaction, Nasense Labs will cease to be an associate company.
During the quarter, the company's consolidated results included performance contributions from multiple subsidiaries, including NACL Spec-Chem Limited, NACL Multichem Private Limited, LR Research Laboratories Private Limited, NACL Agri-Solutions Private Limited, Nagarjuna Agrichem (Australia) Pty Limited, and NACL Industries (Nigeria) Limited.
The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) 34 and reviewed by statutory auditors S.R. Batliboi & Associates LLP, who issued an unmodified review report on the interim financial statements.
Profit after tax was ₹20.84 Cr for the reported quarter. EPS was ₹0.89 for the reported quarter.
01 · Business model
What does NACL Industries do?
NACL Industries Limited is primarily engaged in the farm inputs business, focusing on the manufacture and sale of crop protection solutions, agrochemicals, and formulations. The company operates through its manufacturing facilities and distributes its agricultural chemical products domestically and internationally.
As part of its operational structure, the company maintains a consolidated corporate scope comprising several domestic and international subsidiaries involved in chemical manufacturing, research laboratories, and agricultural solutions, alongside an associate company.
02 · Historical context
What shaped the business before this quarter
In December 2025, the company completed a rights issue of 32,501,851 fully paid-up equity shares at INR 76.70 per share (including a premium of INR 75.70), raising gross proceeds of INR 24,771 lakhs to fund debt repayment and general corporate purposes.
03 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹383.33 Cr |
| Total income | ₹385.22 Cr |
| Profit before tax | ₹28.33 Cr |
| Profit after tax | ₹20.84 Cr |
| EPS | ₹0.89 |
Financial interpretation
What the reported numbers mean
Profit after tax represented 5.4% of reported quarterly operating revenue. This is a calculated net-profit-to-sales ratio, not a company-reported operating margin. It measures the outcome after expenses and tax; it does not, by itself, establish how margins changed versus another period.
Profit before tax was equivalent to 7.4% of quarterly operating revenue. The distinction between pre-tax and post-tax profit matters when interpreting earnings; neither ratio identifies an underlying cost driver without a properly matched comparative period.
Total income exceeded operating revenue by ₹1.89 crore. This is the disclosed difference between the two lines, not incremental sales. The distinction matters when assessing how much of the quarter’s reported income came from the operating top line.
Ratios above are calculated from the reported quarterly figures. They are analytical descriptions, not company-reported margin guidance or an investment recommendation.
04 · Why it moved
Why the quarter looked the way it did
What drove revenue
Revenue from operations was primarily driven by the demand for farm inputs and crop protection formulations across domestic and international markets during the quarter.
What drove margins
Cost of raw materials and packing materials consumed represented the largest operational outflow, amounting to INR 342.76 crore for the quarter.
Employee benefit expenses stood at INR 11.40 crore, while finance costs amounted to INR 6.07 crore and depreciation and amortisation expenses were recorded at INR 8.90 crore.
05 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
The company and its group operate primarily in a single significant business segment, which is farm inputs, in accordance with Ind AS 108.
Geography and market mix
The consolidated group includes operating entities in India, Australia, and Nigeria, providing geographic reach across international agricultural markets.
06 · Strategy & new businesses
How the company is trying to change its growth mix
The board approved the sale of the company's entire equity stake in associate company Nasense Labs Private Limited for INR 8.15 crore, subject to customary closing conditions under a Share Purchase Agreement.
07 · Reported developments
What changed operationally
The statutory auditors issued an unmodified review report on both standalone and consolidated financial results for the quarter ended June 30, 2026.
08 · Pressure points & risks
What is not going smoothly
Certain subsidiaries, including NACL Spec-Chem Limited, reported net losses for the quarter, reflecting developmental and operational expenses in nascent business units.
09 · Items worth noticing
The line items that can distort a quick read
The board approved the divestment of Nasense Labs Private Limited, which contributed 10.93% of turnover and 18.12% of net worth in FY2025.
10 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Out of the rights issue proceeds raised in December 2025, INR 18,700 lakhs was utilized for debt repayment and INR 155 lakhs for issue expenses, leaving INR 2,445 lakhs unutilized and deposited in an earmarked bank account pending general corporate deployment.
Capital allocation & funding
A significant portion of debt was repaid using proceeds from the rights issue executed in the previous financial year, lowering ongoing debt-service requirements.
11 · Beyond the numbers
What changed beyond the numbers
Reported update
Nasense Labs Divestment Agreement
The company entered into an agreement to divest its 18.12% net worth-contributing associate company, Nasense Labs Private Limited, to an unconnected buyer for approximately INR 8.15 crore, expected to complete within three months.
12 · Key Q&A
The quarter, answered directly
What does NACL Industries do?
NACL Industries Limited is primarily engaged in the farm inputs business, focusing on the manufacture and sale of crop protection solutions, agrochemicals, and formulations. The company operates through its manufacturing facilities and distributes its agricultural chemical products domestically and internationally.
What is the clearest takeaway from Q1 FY27?
During the first quarter of fiscal year 2027 (ended June 30, 2026), NACL Industries recorded consolidated revenue from operations of INR 383.33 crore and total income of INR 385.22 crore. Profit before tax (PBT) for the quarter stood at INR 28.33 crore, after accounting for finance costs, depreciation, and other operational expenses.
What drove revenue or demand?
Revenue from operations was primarily driven by the demand for farm inputs and crop protection formulations across domestic and international markets during the quarter.
What mattered most for margins or profitability?
Cost of raw materials and packing materials consumed represented the largest operational outflow, amounting to INR 342.76 crore for the quarter.
What changed operationally beyond the headline numbers?
The board approved the sale of the company's entire equity stake in associate company Nasense Labs Private Limited for INR 8.15 crore, subject to customary closing conditions under a Share Purchase Agreement.
What are the main pressure points disclosed for the quarter?
Certain subsidiaries, including NACL Spec-Chem Limited, reported net losses for the quarter, reflecting developmental and operational expenses in nascent business units.
13 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
14 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Completion of Nasense Labs Divestment: Track the formal closing of the share purchase agreement and receipt of the INR 8.15 crore consideration within the anticipated three-month window.
- 02
Utilization of Remaining Rights Issue Proceeds: Monitor the deployment of the remaining unutilized rights issue funds currently held in earmarked bank accounts.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.